Creating optimal treatments for genetic diseases

Developing novel gene therapies to improve lives

“ We are building a leading cell and gene therapy company for patients and families seeking relief from devastating genetic diseases. ”

Matthew Gantz, President and Chief Executive Officer

Courtesy of debra—The Dystrophic Epidermolysis Bullosa Research Association of America and the Oliveira family. Used with permission.

Courtesy of EB Research Partnership and the Attar family. Used with permission.

Helping Patients in Need

Gene Therapy for Dystrophic Epidermolysis Bullosa (DEB)

Learn More